COPD
<ѻý class="page-description">More in COPD
"We should be cautious about using drugs off-label," investigator says
They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert
An immediate appointment to a smoking cessation clinic shows benefit versus usual care
Propellants in metered-dose inhalers are the biggest culprit
"No race is spared, although people of color fare worse," says project leader
Health news and commentary gathered by ѻý staff
Nonphysician program linked to lower all- and specific-cause mortality risks
Gregory Downey, MD, explains how rising temperatures are driving respiratory health problems
YouTuber and physician Dr. Mike discusses possible dangers of burning candles
First-in-class dual phosphodiesterase inhibitor lands broad indication for COPD maintenance
Also in TTHealthWatch: early diagnosis and treatment of COPD and asthma
Asthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
NOTUS study confirms fewer exacerbations with biologic for patients on maximum inhaled therapy
However, trial results don't affirm safety risks suggested by other studies
